MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 287 filers reported holding MYRIAD GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,581,000 | -60.0% | 351,837 | -58.0% | 0.32% | -62.2% |
| Q3 2019 | $23,982,000 | +1.2% | 837,648 | -1.8% | 0.86% | +8.8% |
| Q2 2019 | $23,707,000 | -21.1% | 853,379 | -5.7% | 0.79% | -18.5% |
| Q1 2019 | $30,043,000 | +29.1% | 904,913 | +13.0% | 0.97% | +13.9% |
| Q4 2018 | $23,272,000 | +44.5% | 800,553 | +52.1% | 0.85% | -8.4% |
| Q2 2016 | $16,101,000 | +1127.2% | 526,184 | +741.5% | 0.93% | +875.8% |
| Q4 2013 | $1,312,000 | +143.4% | 62,526 | +172.6% | 0.10% | +82.7% |
| Q3 2013 | $539,000 | -29.8% | 22,934 | -19.8% | 0.05% | -31.6% |
| Q2 2013 | $768,000 | – | 28,589 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |